Yunqi Capital, 5.1% Holder and One of STAAR Surgical Company's Largest Shareholders, Announces Intention to Vote Against the Proposed Sale to Alcon Medical Device Investing
C4 Therapeutics Presents Cemsidomide Phase 1 Multiple Myeloma Data Supporting Potential Best-in-Class Profile at the International Myeloma Society Annual Meeting Biotech Investing
Clearmind Medicine Secures $10 million Securities Purchase Agreement to Explore Strategic Opportunities Biotech Investing
neffy® Approved in Japan as the First and Only Needle-Free Emergency Treatment of Allergic Reactions Biotech Investing
Medtronic secures FDA approval for the Altaviva device, a simple experience for treating urge urinary incontinence Medical Device Investing
ABVC BioPharma Reports US$1.03 Million in Total Licensing Revenues Collected in Q3 to Date, Highlighting High-Margin Business Model Pharmaceutical Investing
